The brachytherapy market size has grown strongly in recent years. It will grow from $1 billion in 2025 to $1.08 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to rise in prostate and gynecological cancer incidence, early adoption of ldr and hdr brachytherapy systems, growing acceptance of localized radiation therapies, expansion of hospital-based oncology treatment programs, increasing availability of radioactive seed implants.
The brachytherapy market size is expected to see strong growth in the next few years. It will grow to $1.42 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to rising demand for image-guided and computer-assisted brachytherapy, growing uptake of electronic brachytherapy solutions, higher adoption in outpatient and specialty oncology clinics, increasing integration of precision planning and dosimetry tools, expanding application of brachytherapy across additional cancer indications. Major trends in the forecast period include increasing adoption of image-guided and precision-targeted brachytherapy procedures, rising use of brachytherapy in prostate, gynecological, and breast cancer treatment, growing preference for localized radiation delivery with reduced tissue exposure, expansion of electronic brachytherapy for outpatient and dermatologic applications, focus on improving treatment accuracy, patient outcomes, and therapy safety.
The growing cancer burden is anticipated to drive the expansion of the brachytherapy market in the coming years. The increase in cancer cases is attributed to aging populations, lifestyle changes, and greater exposure to risk factors such as tobacco use, unhealthy diets, and environmental pollutants. Brachytherapy helps address the rising cancer burden by providing a precise and effective treatment approach that can be adapted for different cancer types, delivering localized therapy while reducing overall treatment duration and limiting side effects. For example, in September 2025, according to the Institute for Health Metrics and Evaluation (IHME), a US-based population health research organization, there were around 18.5 million new cancer cases reported globally in 2023, up from 18 million in 2022, underscoring a year-on-year increase in cancer incidence. Therefore, the growing cancer burden is driving the brachytherapy market.
Key players in the brachytherapy market are concentrating on advancing technological solutions, such as standard afterloader technology, to improve treatment accuracy and effectiveness. Standard afterloader technology automates the delivery of radioactive sources to tumor sites during brachytherapy, ensuring precise administration of radiation doses. For instance, in April 2024, Varian Medical Systems, a US-based medical device manufacturer, collaborated with Maastro, a US-based radiotherapy clinic, to introduce a new brachytherapy applicator. This innovative device, partially 3D-printed and co-developed by Maastro's radiation oncologists, physicists, and Varian experts, enhances HDR brachytherapy treatment for rectal cancer. The applicator is designed to enhance tumor contact and deliver a uniform dose distribution, comparable to contact X-ray brachytherapy (CXB).
In April 2024, GT Medical Technologies Inc., a US-based medical device manufacturer, acquired Cesium-131 and related assets from Isoray Medical to strengthen its supply chain and market position. This strategic acquisition underscores GT MedTech's commitment to expanding the adoption of GammaTile in the US, leveraging Cesium-131 brachytherapy seed manufacturing capabilities. Isoray Medical, also a US-based medical device manufacturer, specializes in brachytherapy products for cancer treatment.
Major companies operating in the brachytherapy market are Elekta AB, IsoRay Inc, CIVCO Medical Solutions, Theragenics Corporation, Eckert & Ziegler BEBIG, IsoAid LLC, Best Medical International Inc, Boston Scientific Corporation, IBA Group, Accuray Incorporated, Cook Medical, Panacea Medical Technologies Pvt Ltd, NorthStar Medical Radioisotopes LLC, International Isotopes Inc, CivaTech Oncology Inc, Huiheng Medical Inc, Radiomedix, Mevion Medical Systems Inc, Qfix, Seno Medical Instruments.
North America was the largest region in the brachytherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brachytherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brachytherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the brachytherapy market by increasing the cost of radioactive seed materials, precision applicators, afterloaders, shielding components, and electronic control systems sourced through global supply networks, leading to higher device manufacturing and procurement costs. The effect is particularly evident across hdr and ldr brachytherapy systems, applicators, and electronic brachytherapy units produced in Asia-Pacific and European radiation therapy manufacturing hubs that depend on imported alloys, electronic assemblies, and safety components. Hospitals and specialty oncology centers are facing extended procurement cycles and pricing pressures as tariff-related expenses move through distributors and project budgets. However, tariffs are also stimulating localized component sourcing, domestic assembly initiatives, and regional technology partnerships, which may strengthen supply resilience and support long-term market stability.
The brachytherapy market research report is one of a series of new reports that provides brachytherapy market statistics, including brachytherapy industry global market size, regional shares, competitors with a brachytherapy market share, detailed brachytherapy market segments, market trends and opportunities, and any further data you may need to thrive in the brachytherapy industry. This brachytherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Brachytherapy is a form of radiotherapy where radioactive sources are placed directly into or near the tumor, enabling targeted delivery of radiation to cancerous tissues while minimizing exposure to surrounding healthy tissues. It is widely used for treating cancers such as prostate, cervical, and skin cancers, providing a localized and effective treatment option.
The main types of brachytherapy include applicators and afterloaders, as well as electronic brachytherapy. Applicators are devices used to deliver radioactive sources directly to treatment sites, while afterloaders automate the process of placing these sources, ensuring precision and safety in brachytherapy treatments. Brachytherapy can be administered in high-dose rate (HDR) or low-dose rate (LDR), applied in treatments for prostate cancer, gynecological cancer, breast cancer, and various medical conditions. End users typically include hospitals, specialty clinics, and other healthcare facilities.
The brachytherapy market consists of revenues earned by entities by providing services such as treatment planning, procedure administration, and post-treatment care. The market value includes the value of related goods sold by the service provider or included within the service offering. The brachytherapy market also includes sales of radioactive seeds, applicators, imaging and planning systems, and treatment delivery systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The brachytherapy market size is expected to see strong growth in the next few years. It will grow to $1.42 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to rising demand for image-guided and computer-assisted brachytherapy, growing uptake of electronic brachytherapy solutions, higher adoption in outpatient and specialty oncology clinics, increasing integration of precision planning and dosimetry tools, expanding application of brachytherapy across additional cancer indications. Major trends in the forecast period include increasing adoption of image-guided and precision-targeted brachytherapy procedures, rising use of brachytherapy in prostate, gynecological, and breast cancer treatment, growing preference for localized radiation delivery with reduced tissue exposure, expansion of electronic brachytherapy for outpatient and dermatologic applications, focus on improving treatment accuracy, patient outcomes, and therapy safety.
The growing cancer burden is anticipated to drive the expansion of the brachytherapy market in the coming years. The increase in cancer cases is attributed to aging populations, lifestyle changes, and greater exposure to risk factors such as tobacco use, unhealthy diets, and environmental pollutants. Brachytherapy helps address the rising cancer burden by providing a precise and effective treatment approach that can be adapted for different cancer types, delivering localized therapy while reducing overall treatment duration and limiting side effects. For example, in September 2025, according to the Institute for Health Metrics and Evaluation (IHME), a US-based population health research organization, there were around 18.5 million new cancer cases reported globally in 2023, up from 18 million in 2022, underscoring a year-on-year increase in cancer incidence. Therefore, the growing cancer burden is driving the brachytherapy market.
Key players in the brachytherapy market are concentrating on advancing technological solutions, such as standard afterloader technology, to improve treatment accuracy and effectiveness. Standard afterloader technology automates the delivery of radioactive sources to tumor sites during brachytherapy, ensuring precise administration of radiation doses. For instance, in April 2024, Varian Medical Systems, a US-based medical device manufacturer, collaborated with Maastro, a US-based radiotherapy clinic, to introduce a new brachytherapy applicator. This innovative device, partially 3D-printed and co-developed by Maastro's radiation oncologists, physicists, and Varian experts, enhances HDR brachytherapy treatment for rectal cancer. The applicator is designed to enhance tumor contact and deliver a uniform dose distribution, comparable to contact X-ray brachytherapy (CXB).
In April 2024, GT Medical Technologies Inc., a US-based medical device manufacturer, acquired Cesium-131 and related assets from Isoray Medical to strengthen its supply chain and market position. This strategic acquisition underscores GT MedTech's commitment to expanding the adoption of GammaTile in the US, leveraging Cesium-131 brachytherapy seed manufacturing capabilities. Isoray Medical, also a US-based medical device manufacturer, specializes in brachytherapy products for cancer treatment.
Major companies operating in the brachytherapy market are Elekta AB, IsoRay Inc, CIVCO Medical Solutions, Theragenics Corporation, Eckert & Ziegler BEBIG, IsoAid LLC, Best Medical International Inc, Boston Scientific Corporation, IBA Group, Accuray Incorporated, Cook Medical, Panacea Medical Technologies Pvt Ltd, NorthStar Medical Radioisotopes LLC, International Isotopes Inc, CivaTech Oncology Inc, Huiheng Medical Inc, Radiomedix, Mevion Medical Systems Inc, Qfix, Seno Medical Instruments.
North America was the largest region in the brachytherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brachytherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brachytherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the brachytherapy market by increasing the cost of radioactive seed materials, precision applicators, afterloaders, shielding components, and electronic control systems sourced through global supply networks, leading to higher device manufacturing and procurement costs. The effect is particularly evident across hdr and ldr brachytherapy systems, applicators, and electronic brachytherapy units produced in Asia-Pacific and European radiation therapy manufacturing hubs that depend on imported alloys, electronic assemblies, and safety components. Hospitals and specialty oncology centers are facing extended procurement cycles and pricing pressures as tariff-related expenses move through distributors and project budgets. However, tariffs are also stimulating localized component sourcing, domestic assembly initiatives, and regional technology partnerships, which may strengthen supply resilience and support long-term market stability.
The brachytherapy market research report is one of a series of new reports that provides brachytherapy market statistics, including brachytherapy industry global market size, regional shares, competitors with a brachytherapy market share, detailed brachytherapy market segments, market trends and opportunities, and any further data you may need to thrive in the brachytherapy industry. This brachytherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Brachytherapy is a form of radiotherapy where radioactive sources are placed directly into or near the tumor, enabling targeted delivery of radiation to cancerous tissues while minimizing exposure to surrounding healthy tissues. It is widely used for treating cancers such as prostate, cervical, and skin cancers, providing a localized and effective treatment option.
The main types of brachytherapy include applicators and afterloaders, as well as electronic brachytherapy. Applicators are devices used to deliver radioactive sources directly to treatment sites, while afterloaders automate the process of placing these sources, ensuring precision and safety in brachytherapy treatments. Brachytherapy can be administered in high-dose rate (HDR) or low-dose rate (LDR), applied in treatments for prostate cancer, gynecological cancer, breast cancer, and various medical conditions. End users typically include hospitals, specialty clinics, and other healthcare facilities.
The brachytherapy market consists of revenues earned by entities by providing services such as treatment planning, procedure administration, and post-treatment care. The market value includes the value of related goods sold by the service provider or included within the service offering. The brachytherapy market also includes sales of radioactive seeds, applicators, imaging and planning systems, and treatment delivery systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Brachytherapy Market Characteristics
3. Brachytherapy Market Supply Chain Analysis
4. Global Brachytherapy Market Trends and Strategies
5. Brachytherapy Market Analysis of End Use Industries
7. Global Brachytherapy Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Brachytherapy Total Addressable Market (TAM) Analysis for the Market
9. Brachytherapy Market Segmentation
10. Brachytherapy Market Regional and Country Analysis
11. Asia-Pacific Brachytherapy Market
12. China Brachytherapy Market
13. India Brachytherapy Market
14. Japan Brachytherapy Market
15. Australia Brachytherapy Market
16. Indonesia Brachytherapy Market
17. South Korea Brachytherapy Market
18. Taiwan Brachytherapy Market
19. South East Asia Brachytherapy Market
20. Western Europe Brachytherapy Market
21. UK Brachytherapy Market
22. Germany Brachytherapy Market
23. France Brachytherapy Market
24. Italy Brachytherapy Market
25. Spain Brachytherapy Market
26. Eastern Europe Brachytherapy Market
27. Russia Brachytherapy Market
28. North America Brachytherapy Market
29. USA Brachytherapy Market
30. Canada Brachytherapy Market
31. South America Brachytherapy Market
32. Brazil Brachytherapy Market
33. Middle East Brachytherapy Market
34. Africa Brachytherapy Market
36. Brachytherapy Market Competitive Landscape and Company Profiles
37. Brachytherapy Market Other Major and Innovative Companies
40. Brachytherapy Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Brachytherapy Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses brachytherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for brachytherapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The brachytherapy market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Seeds; Applicators And Afterloaders; Electronic Brachytherapy2) By Dosage Type: High-Dose Rate (HDR) Brachytherapy; Low-Dose Rate (LDR) Brachytherapy
3) By Application: Prostate Cancer; Gynecological Cancer; Breast Cancer; Other Applications
4) By End-User: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Seeds: Iodine-125 Seeds; Palladium-103 Seeds; Cesium-131 Seeds; Other Radioactive Seeds2) By Applicators And Afterloaders: Prostate Applicators; Vaginal Applicators; Interstitial Applicators; Skin Applicators; Afterloaders
3) By Electronic Brachytherapy: Electronic Brachytherapy Units; Electronic Brachytherapy Sources
Companies Mentioned: Elekta AB; IsoRay Inc; CIVCO Medical Solutions; Theragenics Corporation; Eckert & Ziegler BEBIG; IsoAid LLC; Best Medical International Inc; Boston Scientific Corporation; IBA Group; Accuray Incorporated; Cook Medical; Panacea Medical Technologies Pvt Ltd; NorthStar Medical Radioisotopes LLC; International Isotopes Inc; CivaTech Oncology Inc; Huiheng Medical Inc; Radiomedix; Mevion Medical Systems Inc; Qfix; Seno Medical Instruments
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Brachytherapy market report include:- Elekta AB
- IsoRay Inc
- CIVCO Medical Solutions
- Theragenics Corporation
- Eckert & Ziegler BEBIG
- IsoAid LLC
- Best Medical International Inc
- Boston Scientific Corporation
- IBA Group
- Accuray Incorporated
- Cook Medical
- Panacea Medical Technologies Pvt Ltd
- NorthStar Medical Radioisotopes LLC
- International Isotopes Inc
- CivaTech Oncology Inc
- Huiheng Medical Inc
- Radiomedix
- Mevion Medical Systems Inc
- Qfix
- Seno Medical Instruments
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.08 Billion |
| Forecasted Market Value ( USD | $ 1.42 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
